151 related articles for article (PubMed ID: 12396872)
1. The pattern of xenobiotic-metabolizing enzymes in the human pancreas.
Standop J; Schneider MB; Ulrich A; Chauhan S; Moniaux N; Büchler MW; Batra SK; Pour PM
J Toxicol Environ Health A; 2002 Oct; 65(19):1379-400. PubMed ID: 12396872
[TBL] [Abstract][Full Text] [Related]
2. Differences in the expression of xenobiotic-metabolizing enzymes between islets derived from the ventral and dorsal anlage of the pancreas.
Standop J; Ulrich AB; Schneider MB; Büchler MW; Pour PM
Pancreatology; 2002; 2(6):510-8. PubMed ID: 12435863
[TBL] [Abstract][Full Text] [Related]
3. Differences in immunohistochemical expression of xenobiotic-metabolizing enzymes between normal pancreas, chronic pancreatitis and pancreatic cancer.
Standop J; Schneider M; Ulrich A; Büchler MW; Pour PM
Toxicol Pathol; 2003; 31(5):506-13. PubMed ID: 14692619
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of carcinogen-metabolizing enzymes within the rat and hamster exocrine pancreas.
Kawabata TT; Wick DG; Guengerich FP; Baron J
Cancer Res; 1984 Jan; 44(1):215-23. PubMed ID: 6418377
[TBL] [Abstract][Full Text] [Related]
5. Induction of drug-metabolizing enzymes in human pancreatic cancer and chronic pancreatitis.
Foster JR; Idle JR; Hardwick JP; Bars R; Scott P; Braganza JM
J Pathol; 1993 Apr; 169(4):457-63. PubMed ID: 8501544
[TBL] [Abstract][Full Text] [Related]
6. Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium.
Lakehal F; Wendum D; Barbu V; Becquemont L; Poupon R; Balladur P; Hannoun L; Ballet F; Beaune PH; Housset C
Hepatology; 1999 Dec; 30(6):1498-506. PubMed ID: 10573530
[TBL] [Abstract][Full Text] [Related]
7. Cytochrome 3A and 2E1 in human liver tissue: Individual variations among normal Japanese subjects.
Hata S; Miki Y; Fujishima F; Sato R; Okaue A; Abe K; Ishida K; Akahira J; Unno M; Sasano H
Life Sci; 2010 Mar; 86(11-12):393-401. PubMed ID: 20102722
[TBL] [Abstract][Full Text] [Related]
8. Transcript profiling of enzymes involved in detoxification of xenobiotics and reactive oxygen in human normal and simian virus 40 T antigen-immortalized oral keratinocytes.
Vondracek M; Weaver DA; Sarang Z; Hedberg JJ; Willey JC; Wärngård L; Grafström RC
Int J Cancer; 2002 Jun; 99(6):776-82. PubMed ID: 12115477
[TBL] [Abstract][Full Text] [Related]
9. Sex-specific effects of gestational and lactational coexposure to lead and cadmium on hepatic phase I and phase II xenobiotic/steroid-metabolizing enzymes and antioxidant status.
Pillai P; Patel R; Pandya C; Gupta S
J Biochem Mol Toxicol; 2009; 23(6):419-31. PubMed ID: 20024958
[TBL] [Abstract][Full Text] [Related]
10. In situ localization and distribution of xenobiotic-activating enzymes and aryl hydrocarbon hydroxylase activity in lungs of untreated rats.
Voigt JM; Kawabata TT; Burke JP; Martin MV; Guengerich FP; Baron J
Mol Pharmacol; 1990 Feb; 37(2):182-91. PubMed ID: 2106064
[TBL] [Abstract][Full Text] [Related]
11. Candidate genetic modifiers of individual susceptibility to renal cell carcinoma: a study of polymorphic human xenobiotic-metabolizing enzymes.
Longuemaux S; Deloménie C; Gallou C; Méjean A; Vincent-Viry M; Bouvier R; Droz D; Krishnamoorthy R; Galteau MM; Junien C; Béroud C; Dupret JM
Cancer Res; 1999 Jun; 59(12):2903-8. PubMed ID: 10383153
[TBL] [Abstract][Full Text] [Related]
12. ErbB2 oncogene antibodies differentiate between the normal and diseased pancreas, and between chronic pancreatitis and pancreatic cancer.
Standop J; Schneider M; Ulrich A; Mathiak G; Brand RE; Buechler MW; Pour PM
Oncol Rep; 2004 Dec; 12(6):1309-15. PubMed ID: 15547756
[TBL] [Abstract][Full Text] [Related]
13. Drug metabolizing enzyme expression in rat choroid plexus: effects of in vivo xenobiotics treatment.
Gradinaru D; Minn AL; Artur Y; Minn A; Heydel JM
Arch Toxicol; 2009 Jun; 83(6):581-6. PubMed ID: 19023562
[TBL] [Abstract][Full Text] [Related]
14. Species differences in the distribution of drug-metabolizing enzymes in the pancreas.
Ulrich AB; Standop J; Schmied BM; Schneider MB; Lawson TA; Pour PM
Toxicol Pathol; 2002; 30(2):247-53. PubMed ID: 11950168
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of the xenobiotic-metabolizing Cytochrome P450 expression pattern in human lung tissue by immunochemical and activity determination.
Bernauer U; Heinrich-Hirsch B; Tönnies M; Peter-Matthias W; Gundert-Remy U
Toxicol Lett; 2006 Jul; 164(3):278-88. PubMed ID: 16483733
[TBL] [Abstract][Full Text] [Related]
16. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
17. Xenobiotic metabolism and disposition in human lung: transcript profiling in non-tumoral and tumoral tissues.
Leclerc J; Courcot-Ngoubo Ngangue E; Cauffiez C; Allorge D; Pottier N; Lafitte JJ; Debaert M; Jaillard S; Broly F; Lo-Guidice JM
Biochimie; 2011 Jun; 93(6):1012-27. PubMed ID: 21376776
[TBL] [Abstract][Full Text] [Related]
18. Comparative aflatoxin B(1) activation and cytotoxicity in human bronchial cells expressing cytochromes P450 1A2 and 3A4.
Van Vleet TR; Macé K; Coulombe RA
Cancer Res; 2002 Jan; 62(1):105-12. PubMed ID: 11782366
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome P450 enzyme levels in HepG2 cells and cryopreserved primary human hepatocytes and their induction in HepG2 cells.
Westerink WM; Schoonen WG
Toxicol In Vitro; 2007 Dec; 21(8):1581-91. PubMed ID: 17637504
[TBL] [Abstract][Full Text] [Related]
20. Induction of cytochrome P450 1A1 and 1A2 by hyperoxia.
Okamoto T; Mitsuhashi M; Fujita I; Sindhu RK; Kikkawa Y
Biochem Biophys Res Commun; 1993 Dec; 197(2):878-85. PubMed ID: 8267628
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
